Schedule 13D ownership disclosure

NAVIDEA BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 63937X202

Event date: 2024-02-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
61.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-010817
Form type
SC 13D/A
Filer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK
CIK 810509
Filed
Feb 05, 2024
Reporting period
Feb 05, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub